Cargando…

Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson’s Disease

[Image: see text] Parkinson’s disease (PD), an age-related neurodegenerative disorder that results from a progressive loss of dopaminergic neurons has an enormous economical and human cost. Unfortunately, only symptomatic treatment such as dopamine replacement therapy is available. Therefore, drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morales-Garcia, José A., Salado, Irene G., Sanz-San Cristobal, Marina, Gil, Carmen, Pérez-Castillo, Ana, Martínez, Ana, Pérez, Daniel I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2017
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044573/ https://www.ncbi.nlm.nih.gov/pubmed/30023743 http://dx.doi.org/10.1021/acsomega.7b00869

Ejemplares similares

Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis
por: Salado, Irene G., et al.
Publicado: (2014)

Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia
por: Alquezar, Carolina, et al.
Publicado: (2016)

Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
por: Martínez-González, Loreto, et al.
Publicado: (2020)

C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson’s Disease
por: Sierra-Magro, Ana, et al.
Publicado: (2023)

Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy
por: Alarcon-Gil, Jesus, et al.
Publicado: (2022)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson’s disease
por: Morales-Garcia, Jose A., et al.
Publicado: (2017)

Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease
por: Morales-Garcia, Jose A., et al.
Publicado: (2011)

CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP
por: Roth, Aileen, et al.
Publicado: (2021)

CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma
por: Burger, Karen L., et al.
Publicado: (2023)

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo
por: Morales-Garcia, Jose A., et al.
Publicado: (2020)

Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder
por: Boateng, Comfort A., et al.
Publicado: (2023)

Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
por: Van Bulck, Michiel, et al.
Publicado: (2019)

Inhibition of Glioblastoma Growth by the Thiadiazolidinone Compound TDZD-8
por: Aguilar-Morante, Diana, et al.
Publicado: (2010)

Novel group-based QSAR and combinatorial design of CK-1δ inhibitors as neuroprotective agents
por: Joshi, Kopal, et al.
Publicado: (2016)

Synthesis, Characterization and Biological Evaluation of Benzothiazole–Isoquinoline Derivative
por: Liu, Weihua, et al.
Publicado: (2022)

Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ
por: Hernandez-Encinas, Elena, et al.
Publicado: (2016)

CK1δ Kinase Activity Is Modulated by Chk1-Mediated Phosphorylation
por: Bischof, Joachim, et al.
Publicado: (2013)

CK1δ as a potential therapeutic target to treat bladder cancer
por: Lin, Yu-Chen, et al.
Publicado: (2020)

Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer’s Disease
por: Roth, Aileen, et al.
Publicado: (2022)

Neurite Outgrowth of Mature Retinal Ganglion Cells and PC12 Cells Requires Activity of CK1δ and CK1ε
por: Bischof, Joachim, et al.
Publicado: (2011)

Role of C/EBPβ Transcription Factor in Adult Hippocampal Neurogenesis
por: Cortes-Canteli, Marta, et al.
Publicado: (2011)

Zebrafish as model system for the biological characterization of CK1 inhibitors
por: Meier, Laura, et al.
Publicado: (2023)

New Conjugated Benzothiazole-N-oxides: Synthesis and Biological Activity
por: Gajdoš, Peter, et al.
Publicado: (2009)

Synthetic Approaches to Biologically Active C-2-Substituted Benzothiazoles
por: Shainyan, Bagrat A., et al.
Publicado: (2022)

Design, Synthesis and Biological Activities of (Thio)Urea Benzothiazole Derivatives
por: Mendieta-Wejebe, Jessica E., et al.
Publicado: (2023)

CK1δ/ε protein kinase primes the PER2 circadian phosphoswitch
por: Narasimamurthy, Rajesh, et al.
Publicado: (2018)

The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer
por: Wang, Zhongyuan, et al.
Publicado: (2021)

A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
por: Bolcato, Giovanni, et al.
Publicado: (2021)

The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design
por: Cozza, Giorgio
Publicado: (2017)

Synthesis and Pharmacological Evaluation of Azetidin-2-ones and Thiazolidin-4-ones Encompassing Benzothiazole
por: Gurupadayya, B. M., et al.
Publicado: (2008)

QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease
por: Sebastián-Pérez, Víctor, et al.
Publicado: (2019)

Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Potential Anticonvulsant Agents
por: Liu, Da-Chuan, et al.
Publicado: (2016)

Targeting of the circadian clock via CK1δ/ε to improve glucose homeostasis in obesity
por: Cunningham, Peter S., et al.
Publicado: (2016)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Site-specific phosphorylation of casein kinase 1 δ (CK1δ) regulates its activity towards the circadian regulator PER2
por: Eng, Gracie Wee Ling, et al.
Publicado: (2017)

Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment
por: Bissaro, Maicol, et al.
Publicado: (2019)

Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization
por: Cruz-Monteagudo, Maykel, et al.
Publicado: (2016)

Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors
por: Cao, Shuang, et al.
Publicado: (2016)

Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tffhai43a83p5slh8vlpdltdru